Ajay Chaudhuri

Research activity per year

Fingerprint

Dive into the research topics where Ajay Chaudhuri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

3 Active
7 Finished

A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes
Chaudhuri, A. (PI)
Novo Nordisk Incorporated
07/22/25 → 12/31/26
University at Buffalo
Project: Research
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety and Efficacy of Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) / Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Chaudhuri, A. (PI)
Akero Therapeutics Incorporated
04/29/25 → 11/30/29
University at Buffalo
Project: Research
A multicentre randomized, double-blind, placebo-controlled Phase 2a study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult patients with Chronic Diabetic Peripheral Neuropathic Pain..
Chaudhuri, A. (PI)
PPD Investigator Services LLC
08/22/23 → 02/1/27
University at Buffalo
Project: Research
FASCINIT: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Denifanstat In Patients With Noncirrhotic Metabolic Dysfunction-Associated Steatohepatitis (Mash) And F2/F3 Fibrosis (Fascinate-3)
Chaudhuri, A. (PI)
Pharmaceutical Research Associates Incorporated
09/15/24 → 03/31/26
University at Buffalo
Project: Research
A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Placebo in Adult Participants with Type 2 Diabetes, Moderate or Severe Renal Impairment with Inadequate..
Chaudhuri, A. (PI)
Lilly USA LLC
02/13/24 → 12/31/25
University at Buffalo
Project: Research

76 Article
25 Review article
13 Comment/debate
11 Letter
More

Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis
Nassar, M., Abosheaishaa, H., Misra, A., Dandona, P., Ghanim, H. & Chaudhuri, A., Mar 2025, In: Diabetes and Metabolism. 51, 2, 101613.
University at Buffalo
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis
Nassar, M., Hassan, A., Ramadan, S., Desouki, M. T., Hassan, M. A. & Chaudhuri, A., Dec 2024, In: BMC Endocrine Disorders. 24, 1, 90.
University at Buffalo
Research output: Contribution to journal › Review article › peer-review

Open Access
7 Scopus citations
The authors reply
Dandona, P., Chaudhuri, A. & Ghanim, H., Jan 18 2024, In: New England Journal of Medicine. 390, 3, p. 292 1 p.
University at Buffalo
Research output: Contribution to journal › Letter › peer-review

Open Access
Semaglutide in Early Type 1 Diabetes
Dandona, P., Chaudhuri, A. & Ghanim, H., 2023, In: New England Journal of Medicine. 389, 10, p. 958-959 2 p.
University at Buffalo
Research output: Contribution to journal › Letter › peer-review
53 Scopus citations
Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials
Chaudhuri, A., Ghanim, H. & Arora, P., Mar 2022, In: Diabetes, Obesity and Metabolism. 24, 3, p. 365-376 12 p.
University at Buffalo
Research output: Contribution to journal › Review article › peer-review

Open Access
89 Scopus citations

Ajay Chaudhuri

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety and Efficacy of Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) / Metabolic Dysfunction-Associated Steatohepatitis (MASH)

A multicentre randomized, double-blind, placebo-controlled Phase 2a study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult patients with Chronic Diabetic Peripheral Neuropathic Pain..

FASCINIT: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Denifanstat In Patients With Noncirrhotic Metabolic Dysfunction-Associated Steatohepatitis (Mash) And F2/F3 Fibrosis (Fascinate-3)

A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Placebo in Adult Participants with Type 2 Diabetes, Moderate or Severe Renal Impairment with Inadequate..

Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis

Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis

The authors reply

Semaglutide in Early Type 1 Diabetes

Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials

Ajay Chaudhuri

Fingerprint

Collaborations and top research areas from the last five years

Grants & Projects

Research output